Chloroform is being administered to male Osborne-Mendel rats and to female B6C3F1 mice at concentrations of 0 (negative control), 200, 400, 900 or 1800 ppm in the drinking water. Matched control groups of both species receive a volume of water identical to that consumed by the corresponding 1800 ppm groups. At this writing, the animals have completed 23 months on test. Negative control and CHCl3-treated rat groups have shown typical growth curves, with dose-related relative decrements in body weight evident throughout the study. Following decreases in CHCl3 groups during the first 8 weeks, rat water consumption values have continued to increase slowly, but persistent relative dose-related decrements are evident. No initial treatment-related decrements are evident. No initial treatment-related mortality was seen in the rats. Survival is 21, 41, 45, 76, 70 and 64% for the negative control, 200, 400, 900, 1800 ppm and matched control groups, respectively. Survival values for mice at three weeks were 99, 94, 74 and 76% for the 200, 400, 900 and 1800 ppm groups, respectively. Mortality was apparently related to markedly decreased fluid consumption among some of the treated mice. Subsequent mortality has been less than 15% for all mouse groups. Except for acclimation effects during the first 2-3 weeks, body weights for the treated mouse groups have been generally within 10%o of negative control values. Tissue changes in decedents have been similar in treated and control groups, both in rats and mice. Terminal sacrifice and histologic evaluations will be initiated after completion of 24 months on test.
Introduction
There have been several studies of tumorigenesis induced in animals by chloroform. Eschenbrenner (1) reported hepatomas induced in female Strain A mice receiving 0.3 or 0.6 mg/kg of chloroform by gavage every four days for three months. In a study conducted by Hazleton Laboratories in 1976 for the National Cancer Institute (2) , chloroform was administered by gavage five times per week for 78 weeks to Osborne-Mendel rats at 90-250 mg/kg/day and to B6C3F1 mice at 100-500 mg/kg/day. Kidney epithelial tumors were in("-ed in male rats and hepatocellular carcinomas in mice of both sexes. Decreased survival rates and body weights were reported in treated rats but were not observed in *SRI International, Menlo Park, California 94025 the mice. Theiss et al. (3) reported no increase in lung adenomas in Strain A mice receiving intraperitoneal injections of chloroform at 80 or 200 mg/kg three times per week for 8 weeks, or two injections at 400 mg/kg.
The present study was designed to evaluate the chronic toxicity and tumorigenicity of chloroform administered in the drinking water to male OsborneMendel rats and to female B6C3F1 mice over a wide range of dose levels.
Methods

Animals
The species and strains of rodents used were those in the earlier study conducted by Hazleton Animals were assigned to experimental groups and cages using a table of random numbers.
For both species cages were rotated on the racks once a week. The racks were rotated on the same schedule within the room to ensure similar conditions for all animals throughout the study.
Control animals were housed in rooms as similar as possible but separate from the chloroform-treated groups.
Chemical Supply
The chloroform used in this program was pesticide quality purchased from Matheson Coleman Bell. The chloroform was analyzed for purity, concentration and stability in the drinking water. Before use, all chloroform was distilled to remove contaminants (diethyl carbonate, ethanol, and phosgene). Distilled water was used throughout the study for control drinking water as well as for the chloroform solutions.
Analytical Chemistry
Quantitative analyses for chloroform in air, water, feed and blood; distillation of chloroform and determination of impurity levels; determination of liver fat/organ weight ratios; and routine monitoring of feed lots for PCBs and chlorinated pesticides were performed. Ambient air in each experimental room was analyzed once every 6 months for chloroform concentrations. The Purina Laboratory Chow was analyzed annually for chloroform concentration with each shipment being analyzed for PCBs and chlorinated pesticides. Chloroform in blood from additional rats placed on test for this purpose was analyzed at 3, 6, 12, and 18 months and will be evaluated at 24 months on study. Once each month the stock solutions prepared on Tuesday were analyzed for chloroform. Additionally, samples from water bottles were analyzed once each month on the Friday following the stock solution analysis. Liver fat/liver weight ratios were examined at 3 and 6 months in both rats and mice. 
Gross and Microscopic Pathology
When any animal in these lifetime studies appeared unlikely to survive until the next scheduled observation, it was sacrificed. This aggressive sacrifice was intended to prevent the loss of information that could occur through autolysis or cannibalization.
All decedents were given a complete gross nec- 
Results
Since this study is still in progress, the results presented here are necessarily incomplete. Nonetheless, they provide a basis for evaluating the progress of the study and some information about the chronic effects of chloroform. Table 2 shows the results of the analyses of the chloroform solutions in the drinking bottles. Chloroform concentrations varied-somewhat over the course of the study, but were generally within ten percent of the nominal values. Clearly, there were no overlapping values between adjacent dose groups.
Survival, water consumption, and body weight patterns for the rats are shown in Figure 1 . Survival has been essentially directly proportional to the chloroform dose level; lowest for the negative controls, next lowest for the 200 and 400 ppm groups, and highest for the matched controls and the 900 and 1800 ppm groups. Water consumption JORGENSON, RUSHBROOK AND JONES has increased slowly over the course of the study in all groups, with the amount consumed inversely proportional to dose level during the first 18 months, then a clustering of the negative control, 200 and 400 ppm groups at a relatively higher level, the 900 ppm group in the middle, and the 1800 ppm group at a lower level. Body weight patterns have shown typical growth curves, the values at any time point being inversely proportional to dose level. Values for the matched control group were above those for the 1800 ppm group during the first year, but the latter group has now caught up with its matched controls.
Survival, water consumption and body weight patterns for the mice are illustrated in Figure 2 . Unlike the rats, there was significant early mortality in the treated mice, particularly at 900 and 1800 ppm. From the second through the eighteenth month very few animals died, but by the twenty-third month some mortality, proportional to dose level, The percent fat in the liver of the rats and the mice at 3 and at 6 months is shown in Table 3 . For the rats, there was no apparent increase in liver fat content in the treated groups at 3 months, but at 6 months there was a significant increase in the 1800 ppm group. In the mice, significant increases in liver fat were apparent at 400-1800 ppm at 3 months and at 900 and 1800 ppm at 6 months.
The hematologic findings in the rats at 6, 12 and 18 months are shown in Tables 4-6 . WBC values were lower in the 1800 ppm group and in the matched controls at 6 and at 12 months. The differences in erythrocyte and hemoglobin parameters at 12 months are consistent with hemoconcentration in the treated groups, but no significant differences were apparent at 18 months.
The blood chemistry data for male rats sacrificed at 6, 12 and 18 months are shown in Tables 7-9 . Although various parameters differed significantly from the negative control values at some time points, there were a number of apparent trends. Chloride, (2, 3) at the higher levels and extended below them at the lower levels.
If it is assumed that the water consumption and body weight data provide indices of food consumption, the increased survival and decreased body weight in rats receiving chloroform are consistent with the well-known increase in longevity associated with caloric restriction (4) . Since caloric restriction also results in reduced age-specific incidences of most pathologic conditions associated with aging (4) , it will be intresting to consider the pathologic findings from the present study when they become available. It is also evident that inclusion of matched controls in long-term studies is extremely important.
In the mice the effect of chloroform on survival was markedly different than that in the rats. It appears that some of the mice rejected the chloroform solutions during the first weeks to such a degree that they were unable to survive. In fact, the only behavioral effect of the chloroform that was discernible during this study was the unthrifty appearance (e.g., lack of vigor, lassitude) of the mice during this time. From the water consumption and body weight data, it is clear that caloric restriction in the mice surviving the first weeks occurred to a much lesser extent than in the rats, if at all.
The increase in liver fat content for the mice was clearly greater than for the rats. It is probable that, in addition to differences between the mouse and the rat in the metabolism of chloroform (5, 6) , the greater caloric restriction in the rats may have been a factor in reducing the relative accumulation of fat in the liver.
While the trends observed in some of the blood chemistry parameters associated with chloroform administration in the rat may be related to a nephrotoxic effect of the chloroform, nephropathy is one of the findings in the negative controls, and no definitive statements about the nephrotoxic effects of chloroform in the present study can be made at this time.
Discussion of the gross necropsy and histologic information will have be delayed until the terminal sacrifices and the histopathologic evaluations have been completed. This study has been supported by EPA Contract 68-03-2616.
